A Decade of Building India’s TB Champion Movement

UPSC Syllabus: Gs Paper 2- Issues relating to development and management of Social Sector/Services relating to Health,

Introduction

India diagnoses and treats over 25 lakh TB cases every year, yet stigma and social exclusion remain strong barriers. Early responses focused mainly on clinical care and ignored lived experiences. Over the last decade, the TB Champion movement has emerged as a community-driven response, where survivors support others and improve awareness. At the same time, new diagnostic tools and policies are expanding India’s efforts to eliminate TB.

Current Status of TB in India

1. High disease burden and social impact: India treats over 25 lakh TB patients annually, but patients continue to face stigma, isolation, and discrimination during treatment.
2. Stigma across vulnerable groups: Stigma affects women, men, transgender persons, children, adolescents, elderly, and socially vulnerable groups, reducing care-seeking behaviour.
3. Undetected cases and transmission risk: Nearly 1,00,000 TB cases remain undetected each year, leading to continued spread in communities.
4. Drug-resistant TB burden: India contributes almost one-fourth of global DR-TB cases, with 1.3–1.5 lakh new cases annually, making it a major public health concern.
5. Progress in incidence and treatment coverage: TB incidence has declined by 21%, while treatment coverage has improved from 53% to 92%.
6. Nature and severity of DR-TB: DR-TB involves resistance to first-line drugs and requires long, toxic treatment with lower cure rates and higher mortality.

Initiatives and Innovations in TB Control

1. Community-driven initiatives
2. a) TB Champion movement: TB survivors act as peer supporters and advocates, challenging the belief that survivors disengage after treatment.
3. b) Survivor to Champion training: A structured curriculum has been formally adopted under the National TB Elimination Programme (NTEP).
4. c) Peer counselling and support: Champions provide one-to-one and group counselling, improving treatment literacy and reducing self-stigma.
5. c) Awareness and last-mile outreach: Community meetings help dispel myths, spread knowledge on symptoms, and guide people on where to seek care.
6. d) Role during COVID-19: TB Champions acted as trusted sources of information on COVID-appropriate behaviour.
7. e) Survivor-led networks: Networks formed across States act as a bridge between patients and service providers, supporting vulnerable groups.
8. System and programme interventions
9. a) National TB Elimination Programme (NTEP): Provides free, high-quality diagnostics and treatment, improving cure rates and reducing mortality.
10. b) Improved case-finding and care models: Active case-finding and differentiated care approaches have strengthened service delivery.
11. c) Improved treatment regimens: Use of shorter and less toxic treatment regimens improves patient experience.
12. d) Nutrition and patient support: Expanded nutrition support helps address treatment challenges and recovery needs.
13. Technological and diagnostic innovations
14. a) WHO recommendations (2025): The World Health Organization (WHO) recommended near point-of-care molecular tests (NPOC), tongue swab samples, and sputum pooling strategies.
15. b) AI-enabled portable screening: Portable chest X-ray (CXR) machines with AI are used under the Pradhan Mantri TB Mukt Bharat Abhiyaan.
16. c) Community-level active screening: Mobile vans equipped with portable CXR and AI enable screening in communities.
17. d) Opportunistic screening using AI: AI algorithms in digital X-rays help identify TB and other respiratory diseases quickly.
18. e) Shift to molecular testing: India scaled up CBNAAT in 2016 and introduced indigenous Truenat in 2020, improving detection.
19. f) Decentralisation of diagnostics: Access to molecular testing has expanded to primary care levels.

Challenges and Gaps

1. Social and community challenges
2. a) Persistent stigma and myths: Misconceptions continue, causing delay in diagnosis and treatment avoidance.
3. b) Long-term impact on survivors: Patients face physical, social, and economic challenges even after cure.
4. c) Network sustainability concerns: Survivor-led networks depend on external funding, making long-term sustainability uncertain.
5. Health system gaps
6. a) Uneven diagnostic access: Molecular testing remains uneven, especially in remote and hard-to-reach areas.
7. b) Delays in resistance testing: Delayed diagnosis leads to empiric first-line treatment and continued transmission.
8. c) Public-private divide: Differences in care and reporting create fragmentation and inconsistency.
9. d) Drug stock-outs and weak referrals: Interruptions in supply and referral systems affect treatment continuity.
10. e) Weak data systems: Inconsistent reporting, especially from the private sector, limits accurate assessment of the crisis.
11. Drug-resistant(DR) TB challenges
12. a) Severe treatment burden: Patients face nausea, joint pain, hearing loss, psychiatric effects, and fatigue.
13. b) Limited scale-up of new regimens: Newer all-oral shorter regimens like BPaLM are not yet widely accessible.
14. c) Socio-economic inequalities: Poverty, overcrowding, food insecurity, and unstable livelihoods increase risk and worsen outcomes.
15. d) Wider consequences: DR-TB leads to preventable deaths, disability, psychological trauma, high health expenditure, income loss, and intergenerational poverty.
16. e) Public health risks: Uncontrolled DR-TB can increase resistance and threaten national health security and economic stability.
17. Diagnostic and research gaps
18. a) Incomplete NAAT coverage: Achieving 100% NAAT testing before treatment requires better sample collection and transport systems.
19. b) Challenges in key populations: Diagnosis remains difficult in children, extra-pulmonary TB (EP-TB), and asymptomatic TB cases.
20. c) Need for new tools: There is a requirement for biomarkers, saliva-based tests, and non-sputum diagnostics.
21. d) Limited real-world evidence: New tools need implementation research and field testing for scale-up decisions.

Way Forward

1. Strengthening community participation
2. a) Expand TB Champion role: Community engagement can reduce stigma and improve treatment adherence.
3. b) Develop sustainable networks: Focus on self-sustaining socio-economic models for survivor-led groups.
4. Improving diagnostics and treatment
5. a) Universal drug-resistance testing: Ensure testing for all TB patients before starting treatment.
6. b) Expand new diagnostic tools: Scale up AI-enabled CXR, molecular tests, NPOC tests, and tongue swabs.
7. c) Reduce diagnostic delays: Improve sample transport systems and turnaround time.
8. Comprehensive DR-TB response
9. a) Scale up safer regimens: Accelerate access to shorter and all-oral treatments like BPaLM (Bedaquiline + Pretomanid + Linezolid + Moxifloxacin).
10. b) Provide holistic care: Include mental health care, nutrition support, and income protection.
11. c) Active case finding and prevention: Focus on household contacts, children, and latent TB infection (LTBI).
12. Strengthening governance and systems
13. a) Integrate private sector: Ensure mandatory reporting, standardised treatment, and accountability.
14. b) Improve monitoring systems: Strengthen platforms like the Nikshay Portal for real-time tracking.
15. Promoting research and innovation
16. a) Develop better diagnostics: Invest in cost-effective biomarkers and tools for children and EP-TB.
17. b) Support implementation research: Ensure evidence-based adoption of new technologies.
18. c) Streamline evaluation and procurement: Ensure tools are assessed by the Indian Council of Medical Research (ICMR) with proper health technology assessment.

Conclusion

India’s TB response now combines community leadership, improved diagnostics, and stronger programmes. The TB Champion movement shows that survivors can drive awareness and support at the grassroots level. However, DR-TB, stigma, and system gaps remain serious challenges. A coordinated approach with early diagnosis, better treatment, strong community participation, and sustained policy commitment is essential to achieve a TB-free India.

Question for practice:

Examine the role of TB Champions, alongside systemic and diagnostic interventions, in strengthening India’s efforts to eliminate tuberculosis.

Source: The Hindu